Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT03742037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Cenerimod 0.5 mg
DRUG: Cenerimod 1 mg
DRUG: Cenerimod 2 mg
DRUG: Cenerimod 4 mg
DRUG: Placebo
DRUG: cenerimod 2 mg (ex-4 mg)

Sponsor

Viatris Innovation GmbH